KELLY WATTS: Open Payments
NPI 1457115933 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $166 |
| Novo Nordisk Inc | 4 | $60 |
| Boston Scientific Corporation | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Medtronic, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: FARXIGA, AIRSUPRA, BREZTRI, Ozempic, WaveWriter Alpha Prime 16, XIFAXAN, JARDIANCE, Wegovy.
Industry payments across SC — which companies pay providers there.
